Vascular smooth muscle cells and neointimal hyperplasia in chronic transplant rejection

Transplantation

Volumn 62, Issue 4, 1996, Pages 502-509

  Geraghty, James G ^a,b   Stoltenberg, Richard L ^a   Sollinger, Hans W ^a   Hullett, Deb A ^a  

^a University of Wisconsin Health   (United States)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; GRAFT REJECTION; INTIMA; MALE; NONHUMAN; ORGAN BLOOD FLOW; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0029840787     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199608270-00013     Document Type: Article

References (17)

1. Cook D. Long term survival in kidney allografts. In: Terasaki PI, ed. Clinical Transplantation. Los Angeles: UCLA Tissue Typing Laboratory, 1987: 277.
2. Land W. Kidney transplantation - state of the art. Transplant Proc 1989; 21: 1425.
3. Tilney NL, Chang A, Milford EL, et al. Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts. Ann Surg 1991; 214: 42.
4. Ross R. Atherosclerosis: a defence mechanism gone awry. Am J Pathol 1993; 143: 987.
5. Hayry P, Mennander A, Tiisala S, et al. Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis. Transplant Proc 1991; 23: 611.
6. Mosse PRL, Campbell GR, Wang ZL, Campbell J H. Smooth muscle phenotypic expression in human carotid arteries. Lab Invest 1985; 53: 566.
7. Glukhova MA, Kabakov AE, Frid MG, et al. Modulation of aortic smooth muscle cell phenotype: a study of muscle specific variants of vinculin, caldesmon and actin expression. Proc Natl Acad Sci USA 1988; 85: 9542.
8. Stoltenberg RL, Geraghty JG, Steele DM, Kennedy E, Hullett DA, Sollinger HW. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine A. Transplantation (in press).
9. Campbell JH and Campbell GR. Cellular interactions in the artery wall. In: Huynor S, Ludbrook J, Shaw J, McGrath M. The peripheral circulation. New York: Elsevier, 1984: 33.
10. Gonzales-Crussi F. Vasculogenesis in the chick embryo: an ultrastructural study. Am J Anat 1971; 130: 441.
11. Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 1993; 73: 193.
12. Dilley RJ, McGeachie JK, Prendergast RJ. A review of the proliferative behaviour, morphology and phenotypes of vascular smooth muscle cells. Arteriosclerosis 1987; 63: 99.
13. Chamley-Campbell JH, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev 1979; 59: 1.
14. Chamley-Campbell JH, Campbell GR. What controls smooth muscle phenotype? Atherosclerosis 1981; 40: 347.
15. Kuro-OM, Nagai C, Nakahora K. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscles and its expression in vascular development and atherogenesis. J Biol Chem 1991; 266: 3768.
16. Giachelli CM, Majesky MW, Schwartz SM. Developmentally regulated cytochrome P450 (A) expression in cultured rat vascular smooth muscle cells. J Biol Chem 1991; 266: 3981.
17. Majesky, MW, Giachelli, CM, Reidy MA, Schwartz, SM. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res 1992; 71: 759.